At the extraordinary general meeting of shareholders held by JUNSHI BIO on December 20, 2024, the election of Mr. Li Zhongxian and Ms. Lu Kun as independent non-executive directors was approved, with their terms lasting until the end of the fourth Board of Directors' term. Both new directors will receive an annual remuneration of RMB 0.2 million each, and their independence standards have been confirmed as compliant with Hong Kong Listing Rules.Subsequently, the company made adjustments to the composition of the Audit Committee and the Strategic Committee. Mr. Li Zhongxian was elected as a member of the Audit Committee; Dr. Wang Gang and Dr. Feng Xiaoyuan were elected as members of the Strategic Committee. After the adjustments, the Audit Committee will...Show More

At the extraordinary general meeting of shareholders held by JUNSHI BIO on December 20, 2024, the election of Mr. Li Zhongxian and Ms. Lu Kun as independent non-executive directors was approved, with their terms lasting until the end of the fourth Board of Directors' term. Both new directors will receive an annual remuneration of RMB 0.2 million each, and their independence standards have been confirmed as compliant with Hong Kong Listing Rules.Subsequently, the company made adjustments to the composition of the Audit Committee and the Strategic Committee. Mr. Li Zhongxian was elected as a member of the Audit Committee; Dr. Wang Gang and Dr. Feng Xiaoyuan were elected as members of the Strategic Committee. After the adjustments, the Audit Committee will consist of two independent non-executive directors and one non-executive director, while the Strategic Committee will consist of three executive directors and two independent non-executive directors.These personnel changes reflect JUNSHI BIO's efforts to strengthen its corporate governance structure and are expected to bring new perspectives and expertise for the company's long-term development. The addition of the new directors and committee members is anticipated to further enhance the company's decision-making capabilities and strategic implementation.